Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Comprehensive Loss

v3.20.4
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Operating expenses:    
General and administrative $ 2,818 $ 1,820
Research and development 6,648 2,373
Acquired in-process research and development 10,502 0
Total operating expenses 19,968 4,193
Loss from operations (19,968) (4,193)
Interest expense (6,847) (1,409)
Fair value change in derivative and warrant liabilities (1,486) (499)
Gain on note extinguishment 3,672 0
Other income (expense), net 9 (68)
Loss before income taxes (24,620) (6,169)
Benefit (provision) for income taxes 0 0
Net loss (24,620) (6,169)
Other comprehensive loss, net of tax 0 0
Comprehensive loss $ (24,620) $ (6,169)
Net loss per share:    
Basic and diluted (Note 10) (in dollars per shares) $ (5.28) $ (2.17)
Number of shares used in per share calculations:    
Basic and diluted (in shares) 4,661,110 2,844,832